Morgan Stanley Maintains Overweight on Treace Medical Concepts, Raises Price Target to $28

Morgan Stanley analyst Drew Ranieri maintains Treace Medical Concepts (NASDAQ:TMCI) with a Overweight and raises the price target from $23 to $28.

Morgan Stanley analyst Drew Ranieri maintains Treace Medical Concepts (NASDAQ:TMCI) with a Overweight and raises the price target from $23 to $28.

Total
0
Shares
Related Posts